NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in NRX Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +2 vs. Q2 2023
- Shares held
- 3.71M
- −6.18M (−62.5%) vs. Q2 2023
- Total value
- $964.7K
- −$3.82M (−79.8%) vs. Q2 2023
- New holders
- 8
- 4 more added
- Sold out
- 6
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $47.6M |
| Q1 2026 | 33 | $13.2M |
| Q4 2025 | 28 | $14.2M |
| Q3 2025 | 24 | $13.0M |
| Q2 2025 | 25 | $9.76M |
| Q1 2025 | 22 | $4.60M |
| Q4 2024 | 25 | $2.31M |
| Q3 2024 | 18 | $1.21M |
| Q2 2024 | 19 | $1.29M |
| Q1 2024 | 31 | $1.76M |
| Q4 2023 | 30 | $1.84M |
| Q3 2023 | 34 | $964.7K |
| Q2 2023 | 32 | $4.78M |
| Q1 2023 | 30 | $2.07M |
| Q4 2022 | 33 | $3.44M |
| Q3 2022 | 30 | $3.04M |
| Q2 2022 | 37 | $2.18M |
| Q1 2022 | 34 | $25.1M |
| Q4 2021 | 38 | $12.4M |
| Q3 2021 | 23 | $16.2M |
| Q2 2021 | 18 | $18.9M |
| Q1 2021 | 1 | $4.00K |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,450,593 | $377.2K | 0.00% | −27,560−1.9% | Reduced |
| Geode Capital Management, LLC | 411,922 | $107.1K | 0.00% | +33,255+8.8% | Added |
| Sabby Management, LLC | 325,000 | $84.5K | 0.27% | −374,731−53.6% | Reduced |
| BlackRock Inc. | 290,714 | $75.6K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 170,419 | $44.0K | 0.00% | −814−0.5% | Reduced |
| Renaissance Technologies LLC | 163,780 | $43.0K | 0.00% | +130,280+388.9% | Added |
| Bridgeway Capital Management, LLC | 160,700 | $41.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 157,182 | $40.9K | 0.00% | +157,182 | New |
| State Street Corp | 114,240 | $29.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 74,996 | $19.5K | 0.00% | 00.0% | Unchanged |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $16.5K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 53,250 | $13.8K | 0.00% | +53,250 | New |
| Morgan Stanley | 47,326 | $12.3K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 43,732 | $11.4K | 0.00% | 00.0% | Unchanged |
| HBK Sorce Advisory LLC | 29,230 | $7.60K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 19,158 | $4.98K | 0.00% | −5,700−22.9% | Reduced |
| United Asset Strategies, Inc. | 18,300 | $4.76K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,099 | $3.67K | 0.00% | +14,099 | New |
| Lido Advisors, LLC | 13,000 | $3.38K | 0.00% | +13,000 | New |
| LPL Financial LLC | 12,358 | $3.21K | 0.00% | +12,358 | New |
| XTX Topco Ltd | 11,809 | $3.07K | 0.00% | +11,809 | New |
| Advisor Group Holdings, Inc. | 11,125 | $2.89K | 0.00% | −15,025−57.5% | Reduced |
| Bank of New York Mellon Corp | 10,129 | $2.63K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 10,000 | $2.60K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 9,644 | $2.51K | 0.00% | −763−7.3% | Reduced |
| Tower Research Capital LLC (TRC) | 9,181 | $2.39K | 0.00% | −18,755−67.1% | Reduced |
| GWM Advisors LLC | 7,125 | $1.85K | 0.00% | +5,000+235.3% | Added |
| Wells Fargo & Company | 5,379 | $1.40K | 0.00% | +39+0.7% | Added |
| UBS Group AG | 1,210 | $315 | 0.00% | −1,548−56.1% | Reduced |
| JPMorgan Chase & Co | 339 | $88 | 0.00% | 00.0% | Unchanged |
| Hibernia Wealth Partners, LLC | 250 | $65 | 0.00% | +250 | New |
| Larson Financial Group LLC | 218 | $57 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 165 | $43 | 0.00% | +165 | New |
| Cutler Group LP | 3,220 | $0 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −5,636,000−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −483,569−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,052−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −940−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −247−100.0% | Sold out |